Insiders · Profile

PERRY MICHAEL S

Director at ARROWHEAD PHARMACEUTICALS · Director at AVITA Medical · Director at Armata Pharmaceuticals. Filing since 29 Jun 2017. CIK 0001250379

Company
Date
Role
Action
Shares
Amount
Of holding
18 Aug 2026
Director
Sold at will
11,600
$1.01M
9.4%
5 Dec 2025
Director
Sold at will
16,250
$991.74K
12.4%
21 Nov 2022
Director
Sold, plan not stated
150,000
$1.08M
39.5%
24 Feb 2022
Chief Executive Officer
Sold, plan not stated
10,812
$94.50K
3.3%
3 Jan 2022
Director
Sold, plan not stated
4,500
$291.19K
5.0%
1 Sep 2021
Chief Executive Officer
Sold, plan not stated
11,220
$232.03K
4.5%
2 Jun 2021
Chief Executive Officer
Sold, plan not stated
23,000
$398.59K
9.3%
4 Jan 2021
Director
Sold, plan not stated
4,000
$304.36K
4.3%
16 Sep 2020
Chief Executive Officer
Sold, plan not stated
9,000
$246.69K
2.1%
15 Sep 2020
Chief Executive Officer
Sold, plan not stated
23,769
$647.23K
5.2%
14 Sep 2020
Chief Executive Officer
Sold, plan not stated
15,092
$407.33K
3.2%
11 Sep 2020
Chief Executive Officer
Sold, plan not stated
20,000
$520.40K
4.7%
10 Sep 2020
Chief Executive Officer
Sold, plan not stated
7,128
$187.18K
1.7%
12 May 2020
Director
Sold, plan not stated
36,000
$1.29M
81.8%
11 Sep 2019
Director
Sold, plan not stated
85,000
$2.55M
70.2%
9 Sep 2019
Director
Sold, plan not stated
100,000
$2.89M
45.2%
22 Mar 2018
Director
Bought
181,820
$200.00K
79.3%
19 Sep 2017
Director
Bought
105,015
no price
84.5%
29 Jun 2017
Director
Bought
5,757
no price
4.9%
19 decisions on file.